Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wellmed Plant is a Thailand-based biotechnology and manufacturing company specializing in the cultivation and extraction of plant-based medicinal compounds, primarily from hemp and cannabis. The company operates an integrated supply chain that includes Wellmed Farm for standardized cultivation and a state-of-the-art extraction plant located in Nonthaburi. Wellmed Plant utilizes advanced technologies such as supercritical CO2 extraction to produce high-purity cannabinoids, including CBD and THC, for pharmaceutical, cosmetic, and food applications. As a leading Contract Manufacturing Organization (CMO) in the Southeast Asian herbal medicine sector, the company provides end-to-end services from raw material sourcing to finished product formulation. Their operations are centered on providing medical-grade botanical extracts that adhere to international quality standards for the global wellness market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Well Med Farm Plant.